| Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis V Mazzaferro, JM Llovet, R Miceli, S Bhoori, M Schiavo, L Mariani, ... The lancet oncology 10 (1), 35-43, 2009 | 2252 | 2009 |
| Metroticket 2.0 model for analysis of competing risks of death after liver transplantation for hepatocellular carcinoma V Mazzaferro, C Sposito, J Zhou, AD Pinna, L De Carlis, J Fan, M Cescon, ... Gastroenterology 154 (1), 128-139, 2018 | 572 | 2018 |
| Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial P De Simone, F Nevens, L De Carlis, HJ Metselaar, S Beckebaum, ... American Journal of Transplantation 12 (11), 3008-3020, 2012 | 356 | 2012 |
| 2018 annual report of the European Liver Transplant Registry (ELTR)–50‐year evolution of liver transplantation R Adam, V Karam, V Cailliez, JG O Grady, D Mirza, D Cherqui, ... Transplant International 31 (12), 1293-1317, 2018 | 299 | 2018 |
| Predictors of long-term survival after liver transplantation for hepatocellular carcinoma C Zavaglia, L De Carlis, AB Alberti, E Minola, LS Belli, AO Slim, A Airoldi, ... Official journal of the American College of Gastroenterology| ACG 100 (12 …, 2005 | 279 | 2005 |
| Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial V Mazzaferro, D Citterio, S Bhoori, M Bongini, R Miceli, L De Carlis, ... The Lancet Oncology 21 (7), 947-956, 2020 | 277 | 2020 |
| Impact of DAAs on liver transplantation: major effects on the evolution of indications and results. An ELITA study based on the ELTR registry LS Belli, G Perricone, R Adam, PA Cortesi, M Strazzabosco, R Facchetti, ... Journal of hepatology 69 (4), 810-817, 2018 | 234 | 2018 |
| Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study F Saliba, P De Simone, F Nevens, L De Carlis, HJ Metselaar, ... American journal of transplantation 13 (7), 1734-1745, 2013 | 203 | 2013 |
| Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial P De Simone, HJ Metselaar, L Fischer, J Dumortier, K Boudjema, ... Liver Transplantation 15 (10), 1262-1269, 2009 | 180 | 2009 |
| Liver transplantation and hepatic resection can achieve cure for hepatocellular carcinoma AD Pinna, T Yang, V Mazzaferro, L De Carlis, J Zhou, S Roayaie, F Shen, ... Annals of surgery 268 (5), 868-875, 2018 | 172 | 2018 |
| Protective role of tacrolimus, deleterious role of age and comorbidities in liver transplant recipients with Covid-19: results from the ELITA/ELTR multi-center European study LS Belli, C Fondevila, PA Cortesi, S Conti, V Karam, R Adam, A Coilly, ... Gastroenterology 160 (4), 1151-1163. e3, 2021 | 155 | 2021 |
| Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term … LS Belli, AK Burroughs, P Burra, AB Alberti, D Samonakis, C Camma, ... Liver Transplantation 13 (5), 733-740, 2007 | 146 | 2007 |
| Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA/EF-CLIF collaborative study (ECLIS) LS Belli, C Duvoux, T Artzner, W Bernal, S Conti, PA Cortesi, SC Sacleux, ... Journal of hepatology 75 (3), 610-622, 2021 | 138 | 2021 |
| Effect of KRAS and BRAF mutations on survival of metastatic colorectal cancer after liver resection: a systematic review and meta-analysis F Tosi, E Magni, A Amatu, G Mauri, K Bencardino, M Truini, S Veronese, ... Clinical colorectal cancer 16 (3), e153-e163, 2017 | 136 | 2017 |
| Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes P Burra, G Germani, R Adam, V Karam, A Marzano, P Lampertico, ... Journal of hepatology 58 (2), 287-296, 2013 | 136 | 2013 |
| Three-year outcomes in de novo liver transplant patients receiving everolimus with reduced tacrolimus: follow-up results from a randomized, multicenter study L Fischer, F Saliba, GM Kaiser, L De Carlis, HJ Metselaar, P De Simone, ... Transplantation 99 (7), 1455-1462, 2015 | 135 | 2015 |
| Long-term efficacy of endoscopic stenting in patients with stricture of the biliary anastomosis after orthotopic liver transplantation AF Rossi, C Grosso, G Zanasi, P Gambitta, M Bini, L De Carlis, ... Endoscopy 30 (04), 360-366, 1998 | 129 | 1998 |
| Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization G Colella, R Bottelli, LD Carlis, CV Sansalone, GF Rondinara, A Alberti, ... Transplant International 11, S193-S196, 1998 | 120 | 1998 |
| Metroticket Investigator Study Group: Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective … V Mazzaferro, JM Llovet, R Miceli, S Bhoori, M Schiavo, L Mariani, ... Lancet Oncol 10 (1), 35-43, 2009 | 111 | 2009 |
| Double-blind comparison of hepatitis C histological recurrence rate in HCV+ liver transplant recipients given basiliximab+ steroids or basiliximab+ placebo, in addition to … F Filipponi, F Callea, M Salizzoni, GL Grazi, LR Fassati, M Rossi, A Risaliti, ... Transplantation 78 (10), 1488-1495, 2004 | 109 | 2004 |
